Click on the subcategory below to find drug monographs for that particular area.
Terminally ill patients with cancer who receive chemotherapy at the end of life are at increased risk of dying in an ICU and receiving CPR and/or mechanical ventilation.
Incyte announced results from a Phase 3 trial of ruxolitinib compared to best available therapy in patients with polycythemia vera who are resistant to or intolerant of hydroxyurea.
The chemical composition of commonly used chemotherapy drugs can be altered so that they only become active when they come into contact with palladium, and cancer patients could one day experience fewer side effects from chemotherapy since this discovery opens the door for more targeted treatments.
Surgical treatment reduces long-term mortality among men with localized prostate cancer compared with those who undergo watchful waiting.
Robot-assisted radical prostatectomy (RARP) is associated with improved surgical margin status compared with open radical prostatectomy (ORP) for intermediate- and high-risk disease and with less use of additional cancer therapy.
Make prescribing decisions with our comparative charts and treatment algorithms.
Quickly and accurately perform clinical calculations.
Download or print easy-to-read disease leaflets for your patients.
This activity can help oncology nurses refresh their knowledge of the risks and treatments for ...
Nurse awareness of this treatment option and the patient selection criteria may be a significant ...